Latest Asx Quotation News

Magellan Financial Group has applied for quotation of over 15 million new shares following a recent transaction, alongside announcing a $20 million Share Purchase Plan targeting further capital raising.

Cosmos Exploration Limited has been reinstated to ASX quotation following the exercise of an Option Agreement and a Placement, ending its trading suspension.

Zeus Resources Limited has had its trading suspension lifted following an announcement on trenching activities at its Casablanca Antimony Project, signaling renewed market engagement.

Identitii Limited’s ID8N securities have been reinstated to trading following the close of its recent rights issue and the resolution of a Takeovers Panel application.

Us1 Critical Minerals Limited’s USCO securities have been suspended from ASX quotation due to non-compliance with key listing rules, raising questions about the company’s regulatory standing and next steps.

Talga Group has lodged a detailed prospectus for issuing attaching and piggyback options to recent Placement and Share Purchase Plan participants, potentially raising up to A$32.7 million upon exercise. The move supports its battery anode production scale-up and international expansion plans.

Aruma Resources Limited has had its AAJOA securities suspended from ASX quotation due to non-compliance with listing rules, raising questions about the company’s regulatory standing.

BPH Energy has extended its options placement offer to 3 February 2026, giving shareholders more time to secure new options at a low exercise price. Directors have already taken up their full entitlements, signalling confidence in the company’s strategic direction.

ECS Botanics Holdings Ltd has seen its ECSO securities suspended from ASX quotation due to non-compliance with listing rules, raising questions about the company’s next steps.

Klevo Rewards Limited has successfully reinstated its ASX listing and completed a $3.4 million capital raise, setting the stage for accelerated growth of its digital wallet and rewards platform.

Epsilon Healthcare has posted a record $2.891 million in receipts for the December 2025 quarter, nearly doubling year-on-year revenue and marking a significant turnaround with its recent ASX reinstatement.

Assetora Limited has announced a $4 million pro-rata rights issue priced at $0.16 per share, with half the offer underwritten by existing shareholders to strengthen its balance sheet and repay debt.